Stocksigma LogoStocksigma Logo

Sandu Pharmaceuticals Reports Zero Fund Deviation for Q Ended 30th Sep'26

Sandu Pharmaceuticals reported nil deviation or variation in preferential issue fund utilization for the quarter ended 30th Sep'26 across three tranches

Sandu Pharmaceuticals Reports Zero Fund Deviation for Q Ended 30th Sep'26

Sandu Pharmaceuticals Ltd · Others (Uncategorized) · 15 Nov 2026, 12:35 am

Sandu Pharmaceuticals Reports Zero Fund Deviation for Q Ended 30th Sep'26 Sandu Pharmaceuticals reported nil deviation or variation in preferential issue fund utilization for the quarter ended 30th Sep'26 across three tranches. Tranche 1 (₹2,63,79,653 raised on 31st Mar'21) and Tranche 2 (₹1,38,05,408 raised on 28th Feb'22) stand 100% utilized toward plant revamping, marketing infrastructure, civil works, and working capital. From Tranche 3 (₹1,31,94,934 raised on 14th Jul'22), ₹66,45,748.19 has been utilized, while the remaining unutilized capital is parked in a fixed deposit with Bank of Baroda via an escrow account.

Original exchange filing (PDF)

More announcements from Sandu Pharmaceuticals Ltd

All Sandu Pharmaceuticals Ltd announcements